statistiche ricercatore

Continente	#
AS - Asia	981
NA - Nord America	517
EU - Europa	292
SA - Sud America	79
AF - Africa	43
Continente sconosciuto - Info sul continente non disponibili	43
Totale	1.955

Nazione	#
US - Stati Uniti d'America	481
VN - Vietnam	247
CN - Cina	222
SG - Singapore	195
IT - Italia	179
HK - Hong Kong	105
BD - Bangladesh	67
BR - Brasile	56
KR - Corea	55
FR - Francia	24
IN - India	23
DE - Germania	21
NL - Olanda	19
JP - Giappone	18
CA - Canada	17
MX - Messico	15
CI - Costa d'Avorio	14
GB - Regno Unito	14
SC - Seychelles	13
AR - Argentina	10
PH - Filippine	10
TH - Thailandia	9
FI - Finlandia	8
ID - Indonesia	7
SE - Svezia	6
EC - Ecuador	5
IQ - Iraq	5
TW - Taiwan	5
ZA - Sudafrica	5
ES - Italia	4
PL - Polonia	4
AT - Austria	3
SA - Arabia Saudita	3
UY - Uruguay	3
AO - Angola	2
CO - Colombia	2
MA - Marocco	2
MU - Mauritius	2
TR - Turchia	2
UA - Ucraina	2
AE - Emirati Arabi Uniti	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
ET - Etiopia	1
GR - Grecia	1
GT - Guatemala	1
HN - Honduras	1
IE - Irlanda	1
IL - Israele	1
IS - Islanda	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
LB - Libano	1
LT - Lituania	1
LV - Lettonia	1
MY - Malesia	1
NP - Nepal	1
OM - Oman	1
PE - Perù	1
PK - Pakistan	1
PR - Porto Rico	1
PY - Paraguay	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
VE - Venezuela	1
ZW - Zimbabwe	1
Totale	1.912

Nome	#
The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry disease	239
DNAJB11 Mutation in ADPKD Patients: Clinical Characteristics in a Monocentric Cohort	222
Clinical Relevance of IFT140 Loss-of-Function Variants in Development of Renal Cysts	201
The need for clinical, genetic and radiological characterization of atypical polycystic kidney disease	194
The Role of Kidney Biopsy in Fabry Disease	163
Functional and histopathologic correlation in the fabry nephropathy with N215S genotype	136
Integrated use of Autosomal Dominant Polycystic Kidney Disease Prediction Tools and Risk Prognostication	131
The impact of a secondary, rare, non-pathogenic PKD1 variant on disease progression in autosomal dominant polycystic kidney disease	121
The Fabry Nephropathy in Patients with N215S Variant	116
Renal outcomes of kidney-liver transplantation and liver transplantation in autosomal dominant polycystic kidney disease patients	114
Coexistence of Alport Syndrome and Fabry Disease in a Female with R112H Variant: Early Progression of Fabry Nephropathy	85
The Fabry Nephropathy in Patients with N215S Variant	79
Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights	60
null	52
CO 08 – Recent advances in the GREASE II study	42
Totale	1.955

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2023/2024	8	0	0	0	0	0	0	0	2	5	0	1	0
2024/2025	216	4	7	4	2	6	2	12	4	10	23	45	97
2025/2026	1.557	106	165	148	140	115	46	273	71	215	99	74	105
2026/2027	174	63	111	0	0	0	0	0	0	0	0	0	0
Totale													1.955

CRIS Current Research Information System